About the 16th Annual Biotech in Europe Forum
The forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry and is highly transactional. The Forum draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. We expect over 600+ delegates and 100+ presenting companies.
The 16th Annual is held for the third time in Basel to be close to the largest biopharma hub in Europe and the Congress Center provides meeting space capable of handling several thousand one- to- one meetings as well as significant exhibition space. The Programme will feature twelve plenary panels/workshops covering BD & Licensing in the main therapeutic areas.
The Meeting will provide a number of networking opportunities via our online 1-2-1 meeting system which allows you to pre-book meetings with all the attendees at the dedicated meeting facilities. We expect more than 1500 meetings to take place throughout the 2 days.
Confirmed Keynotes Include:
Confirmed Speakers & Chairs Include:
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering. The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners.
To view list of confirmed presenters - please click HERE
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.
Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact:
Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.
Pharma Licensing Groups in 2016:
Financial / Advisory / Investors in 2016:
203 Investment Partners
ACXIT Capital Partners
ACXIT Lifesciences GmbH
Advent Life Sciences
Affas Besse Advisors Ltd
Aglaia Oncology Fund
Albion Ventures LLP
Alpha Omega LLC
apo Asset Management
Arthurian Life Sciences Ltd.
Aureae Portae Enterprise Fund
BB Biotech Ventures
Bellevue Asset Management AG
Belsize Asset Management
Bergmann zur Hausen & Cie. GmbH
BioBac BioValley Basel Buisness Angels Club
BioBac BioValley Basel Business Angels Club
BioStart Consulting GmbH
Biotech Alliances International, Inc.
Bird & Bird LLP
Brock Capital Group LLC
Capricorn Venture Partners NV
Colpman Consulting Ltd.
Cukierman & Co. Life Sciences
Deepbridge Capital LLP
Deutsche Bank AG
Edmond de Rothschild Investment Partners
Eminent Venture Capital Corporation / TaiAn Technologies
Ernst & Young
Ernst & Young AG
European Investment Fund
EVA - the Basel life sciences start-up agency
Excellentia Global Partners
F. Hoffmann-La Roche AG Roche Venture Fund
Forbion Capital Partners
fundamenta CAPITAL AG
Gilde Healthcare Partners
Global Life Science Ventures
Global Strategic Medical
Grabulovski Consulting Services
Gurnet Point Capital
HBM Partners AG
Health Advances GmbH
HealthCare Royalty Partners
High-Tech Gruenderfonds Management GmbH
IBB Beteiligungsgesellschaft GmbH
IMI Consulting GmbH
Independent Biotech Advisor
INKEF Capital BV
Inserm Transfert Initiative
Jefferies International Limited
JJ Zwicky & Partners
JP Morgan Healthcare
Kalliste Biotech Fund
View Full List >>>